Prolonged impairment of hematopoiesis after high-dose therapy followed by autologous bone marrow transplantation. [electronic resource]
Producer: 19950623Description: 3320-7 p. digitalISSN:- 0006-4971
- Adolescent
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Bone Marrow -- drug effects
- Bone Marrow Transplantation
- Busulfan -- administration & dosage
- Carmustine -- administration & dosage
- Cell Count
- Child
- Child, Preschool
- Cisplatin -- administration & dosage
- Combined Modality Therapy
- Cyclophosphamide -- administration & dosage
- Cytarabine -- administration & dosage
- Etoposide -- administration & dosage
- Female
- Follow-Up Studies
- Hematopoiesis -- drug effects
- Hematopoietic Cell Growth Factors -- therapeutic use
- Humans
- Male
- Melphalan -- administration & dosage
- Methotrexate -- administration & dosage
- Middle Aged
- Mitoxantrone -- administration & dosage
- Multivariate Analysis
- Neoplasms -- drug therapy
- Prognosis
- Radiation Injuries -- physiopathology
- Treatment Outcome
- Vincristine -- administration & dosage
- Whole-Body Irradiation -- adverse effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.